{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:47:06Z","timestamp":1773802026948,"version":"3.50.1"},"reference-count":21,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Life Biosciences"},{"DOI":"10.13039\/100005440","name":"Center for Scientific Review","doi-asserted-by":"publisher","award":["R01DK128612"],"award-info":[{"award-number":["R01DK128612"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2014079"],"award-info":[{"award-number":["GNT2014079"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n                  <jats:p>Excess body fat is a risk factor for metabolic diseases and is a leading preventable cause of morbidity and mortality worldwide. There is a strong need to find new treatments that decrease the burden of obesity and lower the risk of obesity-related comorbidities, including cardiovascular disease and type 2 diabetes. Pharmacologic mitochondrial uncouplers represent a potential treatment for obesity through their ability to increase nutrient oxidation. Herein, we report the in\u00a0vitro and in\u00a0vivo characterization of compound SHD865, the first compound to be studied in\u00a0vivo in a newly discovered class of imidazolopyrazine mitochondrial uncouplers. SHD865 is a derivative of the furazanopyrazine uncoupler BAM15. SHD865 is a milder mitochondrial uncoupler than BAM15 that results in a lower maximal respiration rate. In a mouse model of diet-induced adiposity, 6-week treatment with SHD865 completely restored normal body composition and glucose tolerance to levels like those of chow-fed controls, without altering food intake. SHD865 treatment also corrected liver steatosis and plasma hyperlipidemia to normal levels comparable with chow-fed controls. SHD865 has maximal oral bioavailability in rats and slow clearance in human microsomes and hepatocytes. Collectively, these data identify the potential of imidazolopyrazine mitochondrial uncouplers as drug candidates for the treatment of obesity-related disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Article Highlights<\/jats:title>\n               <\/jats:sec>","DOI":"10.2337\/db23-0233","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T16:00:50Z","timestamp":1698076850000},"page":"374-384","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":10,"title":["Liver-Selective Imidazolopyrazine Mitochondrial Uncoupler SHD865 Reverses Adiposity and Glucose Intolerance in Mice"],"prefix":"10.2337","volume":"73","author":[{"given":"Martina","family":"Beretta","sequence":"first","affiliation":[{"name":"1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Dai","sequence":"additional","affiliation":[{"name":"2Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen M.","family":"Olzomer","sequence":"additional","affiliation":[{"name":"1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calum S.","family":"Vancuylenburg","sequence":"additional","affiliation":[{"name":"1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Santiago-Rivera","sequence":"additional","affiliation":[{"name":"2Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashleigh M.","family":"Philp","sequence":"additional","affiliation":[{"name":"3St Vincent\u2019s Clinical School, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan R.","family":"Hargett","sequence":"additional","affiliation":[{"name":"4Department of Pharmacology, University of Virginia, Charlottesville, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyong","family":"Li","sequence":"additional","affiliation":[{"name":"4Department of Pharmacology, University of Virginia, Charlottesville, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya P.","family":"Shah","sequence":"additional","affiliation":[{"name":"1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sing-Young","family":"Chen","sequence":"additional","affiliation":[{"name":"1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Alexopoulos","sequence":"additional","affiliation":[{"name":"1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Li","sequence":"additional","affiliation":[{"name":"1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1742-6043","authenticated-orcid":false,"given":"Thurl E.","family":"Harris","sequence":"additional","affiliation":[{"name":"4Department of Pharmacology, University of Virginia, Charlottesville, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Lee","sequence":"additional","affiliation":[{"name":"5Biological Resources Imaging Laboratory, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Wathier","sequence":"additional","affiliation":[{"name":"6Life Biosciences, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Cermak","sequence":"additional","affiliation":[{"name":"6Life Biosciences, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon P.","family":"Tucker","sequence":"additional","affiliation":[{"name":"6Life Biosciences, Boston, MA"},{"name":"7Firebrick Pharma, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Turner","sequence":"additional","affiliation":[{"name":"8Cellular Bioenergetics Laboratory, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Bayliss","sequence":"additional","affiliation":[{"name":"4Department of Pharmacology, University of Virginia, Charlottesville, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Philp","sequence":"additional","affiliation":[{"name":"9Centre for Healthy Ageing, Centenary Institute, Camperdown, New South Wales, Australia"},{"name":"10School of Sport, Exercise and Rehabilitation Sciences, University of Technology Sydney, Sydney, New South Wales, Australia"},{"name":"11Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances L.","family":"Byrne","sequence":"additional","affiliation":[{"name":"1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4731-8548","authenticated-orcid":false,"given":"Webster L.","family":"Santos","sequence":"additional","affiliation":[{"name":"2Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-3238","authenticated-orcid":false,"given":"Kyle L.","family":"Hoehn","sequence":"additional","affiliation":[{"name":"1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia"},{"name":"4Department of Pharmacology, University of Virginia, Charlottesville, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"2024022020221263000_B1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13098-019-0468-0","article-title":"Cardiovascular risk and obesity","volume":"11","author":"Cercato","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"2024022020221263000_B2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer--viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"2024022020221263000_B3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","article-title":"Insulin action and resistance in obesity and type 2 diabetes","volume":"23","author":"Czech","year":"2017","journal-title":"Nat Med"},{"key":"2024022020221263000_B4","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1210\/jc.2006-0557","article-title":"Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status","volume":"91","author":"Shah","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024022020221263000_B5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11695-019-04210-x","article-title":"Definitions of long-term weight regain and their associations with clinical outcomes","volume":"30","author":"Voorwinde","year":"2020","journal-title":"Obes Surg"},{"key":"2024022020221263000_B6","author":"Daneschvar","year":"2016"},{"key":"2024022020221263000_B7","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1021\/acs.jmedchem.7b01182","article-title":"Small molecule mitochondrial uncouplers and their therapeutic potential","volume":"61","author":"Childress","year":"2018","journal-title":"J Med Chem"},{"key":"2024022020221263000_B8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd3138","article-title":"Cellular bioenergetics as a target for obesity therapy","volume":"9","author":"Tseng","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"2024022020221263000_B9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/cells8080795","article-title":"Mitochondrial uncoupling: a key controller of biological processes in physiology and diseases","volume":"8","author":"Demine","year":"2019","journal-title":"Cells"},{"key":"2024022020221263000_B10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13181-011-0162-6","article-title":"2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death","volume":"7","author":"Grundlingh","year":"2011","journal-title":"J Med Toxicol"},{"key":"2024022020221263000_B11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s004240100703","article-title":"FCCP depolarizes plasma membrane potential by activating proton and Na+ currents in bovine aortic endothelial cells","volume":"443","author":"Park","year":"2002","journal-title":"Pflugers Arch"},{"key":"2024022020221263000_B12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.molmet.2013.11.005","article-title":"Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane","volume":"3","author":"Kenwood","year":"2013","journal-title":"Mol Metab"},{"key":"2024022020221263000_B13","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41467-020-16298-2","article-title":"Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice","volume":"11","author":"Alexopoulos","year":"2020","journal-title":"Nat Commun"},{"key":"2024022020221263000_B14","doi-asserted-by":"crossref","first-page":"101684","DOI":"10.1016\/j.molmet.2023.101684","article-title":"Targeting negative energy balance with calorie restriction and mitochondrial uncoupling in db\/db mice","volume":"69","author":"Chen","year":"2023","journal-title":"Mol Metab"},{"key":"2024022020221263000_B15","doi-asserted-by":"crossref","first-page":"154724","DOI":"10.1016\/j.metabol.2021.154724","article-title":"Mitochondrial uncoupler SHC517 reverses obesity in mice without affecting food intake","volume":"117","author":"Chen","year":"2021","journal-title":"Metabolism"},{"key":"2024022020221263000_B16","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1016\/j.bmcl.2015.06.040","article-title":"Structure-activity relationships of furazano[3,4-b]pyrazines as mitochondrial uncouplers","volume":"25","author":"Kenwood","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"2024022020221263000_B17","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1021\/acs.jmedchem.0c00542","article-title":"6-Amino[1,2,5]oxadiazolo[3,4-b]pyrazin-5-ol derivatives as efficacious mitochondrial uncouplers in STAM mouse model of nonalcoholic steatohepatitis","volume":"63","author":"Salamoun","year":"2020","journal-title":"J Med Chem"},{"key":"2024022020221263000_B18","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1021\/acs.jmedchem.2c01573","article-title":"Oxadiazolopyridine derivatives as efficacious mitochondrial uncouplers in the prevention of diet-induced obesity","volume":"66","author":"Murray","year":"2023","journal-title":"J Med Chem"},{"key":"2024022020221263000_B19","doi-asserted-by":"crossref","first-page":"128912","DOI":"10.1016\/j.bmcl.2022.128912","article-title":"Conversion of oxadiazolo[3,4-b]pyrazines to imidazolo[4,5-b]pyrazines via a tandem reduction-cyclization sequence generates new mitochondrial uncouplers","volume":"73","author":"Dai","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"2024022020221263000_B20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","article-title":"Clinical review 124: diabetic dyslipidemia: causes and consequences","volume":"86","author":"Goldberg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024022020221263000_B21","doi-asserted-by":"crossref","first-page":"e12088","DOI":"10.15252\/emmm.202012088","article-title":"BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control","volume":"12","author":"Axelrod","year":"2020","journal-title":"EMBO Mol Med"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/73\/3\/374\/747630\/db230233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/73\/3\/374\/747630\/db230233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T20:22:29Z","timestamp":1708460549000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/73\/3\/374\/153748\/Liver-Selective-Imidazolopyrazine-Mitochondrial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,10,23]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db23-0233","relation":{},"ISSN":["0012-1797"],"issn-type":[{"value":"0012-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,23]]}}}